These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cardiovascular diseases and clinical laboratory examination. (5). Atherosclerosis and abnormal metabolism of lipids]. Hirabaru K; Yamasaki S Rinsho Byori; 1983 Oct; 31(10):1078-82. PubMed ID: 6674578 [No Abstract] [Full Text] [Related]
5. Madelung's disease. Yeh NC; Yang CY; Chou CW; Yen FC; Lee SY; Tien KJ J Clin Endocrinol Metab; 2012 Sep; 97(9):3012-3. PubMed ID: 22701018 [No Abstract] [Full Text] [Related]
6. Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment. Davidson MH Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1582-3. PubMed ID: 18716322 [No Abstract] [Full Text] [Related]
7. [Lipid lowering therapy in the treatment and secondary prevention of ischemic heart disease]. Zimin IuV Kardiologiia; 2003; 43(4):74-83. PubMed ID: 12968608 [No Abstract] [Full Text] [Related]
8. [Lipid metabolism in view of today's new knowledge]. Mertz DP Ther Ggw; 1980 Nov; 119(11):1274-98. PubMed ID: 7466681 [No Abstract] [Full Text] [Related]
9. It's time for CHUMP to change. Mejia V; Carver JR J Invasive Cardiol; 2005 Oct; 17(10):521. PubMed ID: 16204744 [No Abstract] [Full Text] [Related]
10. Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents. Davidson MH Am J Cardiol; 2001 Feb; 87(4A):1A-7A. PubMed ID: 11243600 [No Abstract] [Full Text] [Related]
12. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study. Michos ED; Blumenthal RS J Am Coll Cardiol; 2009 Mar; 53(11):931-5. PubMed ID: 19281922 [TBL] [Abstract][Full Text] [Related]
13. A significant temporal and quantitative relationship exists between high-density lipoprotein levels and acute ischemic stroke presentation. Russman AN; Schultz LR; Zaman IF; Rehman MF; Silver B; Mitsias P; Nerenz DR J Neurol Sci; 2009 Apr; 279(1-2):53-6. PubMed ID: 19195663 [TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk reduced under moderate LDL-C target values]. Laufs U Dtsch Med Wochenschr; 2016 Oct; 141(22):1602. PubMed ID: 27824410 [No Abstract] [Full Text] [Related]
15. [Comparative biochemical analysis of blood serum lipoproteins from human and various animal species]. Lizenko MV; Regerand TI; Bakhirev AM; Lizenko EI Zh Evol Biokhim Fiziol; 2008; 44(5):492-500. PubMed ID: 18959212 [TBL] [Abstract][Full Text] [Related]
17. Genetic and environmental influences on serum lipids and the effects of puberty: a Chinese twin study. Chen TJ; Ji CY; Hu YH Acta Paediatr; 2009 Jun; 98(6):1029-36. PubMed ID: 19292833 [TBL] [Abstract][Full Text] [Related]
18. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]